These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 2076713)

  • 21. Experience with perindopril in normal volunteers.
    Waeber B; Nussberger J; Perret L; Santoni JP; Brunner HR
    Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():35-41. PubMed ID: 2549899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the pharmacokinetics and pharmacodynamics of perindopril, cilazapril and enalapril.
    Louis WJ; Conway EL; Krum H; Workman B; Drummer OH; Lam W; Phillips P; Howes LG; Jackson B
    Clin Exp Pharmacol Physiol Suppl; 1992; 19():55-60. PubMed ID: 1327596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Perindopril as monotherapy in hypertension: a multicenter comparison of two dosing regimens. The Perindopril Study Group.
    Chrysant SG; McDonald RH; Wright JT; Barden PL; Weiss RJ
    Clin Pharmacol Ther; 1993 Apr; 53(4):479-84. PubMed ID: 8477565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experience with perindopril in normal volunteers.
    Waeber B; Nussberger J; Perret L; Santoni JP; Brunner HR
    Clin Exp Hypertens A; 1989; 11 Suppl 2():507-19. PubMed ID: 2605800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the pharmacokinetics and pharmacodynamics of oral doses of perindopril in normotensive Chinese and Caucasian volunteers.
    Anderson PJ; Critchley JA; Tomlinson B; Resplandy G
    Br J Clin Pharmacol; 1995 Apr; 39(4):361-8. PubMed ID: 7640141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of perindopril on blood pressure in humans on different sodium intakes.
    Morgan T; Anderson A; Wilson D; Murphy J; Nowson C
    J Cardiovasc Pharmacol; 1987; 10 Suppl 7():S116-8. PubMed ID: 2485043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiotensin-converting enzyme inhibition as first-line treatment for hypertension.
    Thurston H
    Clin Exp Pharmacol Physiol Suppl; 1992; 19():67-71. PubMed ID: 1395119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Haemodynamic and humoral effects of oral perindopril, an angiotensin converting enzyme inhibitor, in man.
    Lees KR; Reid JL
    Br J Clin Pharmacol; 1987 Feb; 23(2):159-64. PubMed ID: 3030387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A double blind comparison of perindopril and atenolol in essential hypertension.
    Thurston H; Mimran A; Zanchetti A; Creytens G; Rorive G; Brown CL; Santoni JP
    J Hum Hypertens; 1990 Oct; 4(5):547-52. PubMed ID: 2283644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Value of angiotensin converting enzyme inhibitors in the elderly: the example of perindopril.
    Forette F; McClaran J; Delesalle MC; Hervy MP; Bouchacourt P; Henry-Amar M; Santoni JP
    Clin Exp Hypertens A; 1989; 11 Suppl 2():587-603. PubMed ID: 2691131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Captopril versus perindopril: a double blind study in essential hypertension.
    Lees KR; Reid JL; Scott MG; Hosie J; Herpin D; Santoni JP
    J Hum Hypertens; 1989 Feb; 3(1):17-22. PubMed ID: 2657055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ambulatory blood pressure parameters after canrenone addition to existing treatment regimens with maximum tolerated dose of angiotensin-converting enzyme inhibitors/angiotensin II type 1 receptor blockers plus hydrochlorothiazide in uncontrolled hypertensive patients.
    Guasti L; Gaudio G; Lupi A; D'Avino M; Sala C; Mugellini A; Vulpis V; Felis S; Sarzani R; Vanasia M; Maffioli P; Derosa G
    Drug Des Devel Ther; 2017; 11():2293-2300. PubMed ID: 28831241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antihypertensive efficacy and safety of perindopril in mild-to-moderate essential hypertension: results of a double-blind multicenter study versus atenolol.
    Morgan TO; Louis WJ; MacDonald GJ; Conway EL; Bartholomeusz LC; Anderson AI; Cameron DP; Donnelly T; Frewin DB; Hooper MJ
    Am J Med; 1992 Apr; 92(4B):73S-78S. PubMed ID: 1580284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of haemodialysis on the pharmacokinetics of perindoprilat after long-term perindopril.
    Guérin A; Resplandy G; Marchais S; Taillard F; London G
    Eur J Clin Pharmacol; 1993; 44(2):183-7. PubMed ID: 8453964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perindopril/hydrochlorothiazide dose combinations for the treatment of hypertension: a multicenter study.
    Chrysant SG
    J Clin Pharmacol; 1997 Jan; 37(1):47-52. PubMed ID: 9048272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single dose pharmacokinetics of perindopril and its metabolites in hypertensive patients with various degrees of renal insufficiency.
    Verpooten GA; Genissel PM; Thomas JR; De Broe ME
    Br J Clin Pharmacol; 1991 Aug; 32(2):187-92. PubMed ID: 1657092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renoprotect and blood pressure lowering effect of low-dose hydrochlorothiazide added to intensive renin-angiotensin inhibition in hypertensive patients with chronic kidney disease.
    Abe M; Okada K; Maruyama T; Matsumoto K
    Int J Clin Pharmacol Ther; 2009 Aug; 47(8):525-32. PubMed ID: 19640361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perindopril versus captopril: efficacy and acceptability in an Italian multicenter trial.
    Agabiti-Rosei E; Ambrosioni E; Finardi G; Folino P; Gambassi G; Malini P; Marchesi E; Muiesan ML; Semplicini A; Pessina AC
    Am J Med; 1992 Apr; 92(4B):79S-83S. PubMed ID: 1580285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversal of the suppressed kidney renin level in the hypertensive transgenic rat TGR(mRen-2)27 by angiotensin converting enzyme inhibition.
    Tokita Y; Franco-Saenz R; Mulrow PJ
    Am J Hypertens; 1995 Oct; 8(10 Pt 1):1031-9. PubMed ID: 8845072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ACE inhibition but not angiotensin II antagonism reduces plasma fibrinogen and insulin resistance in overweight hypertensive patients.
    Fogari R; Zoppi A; Lazzari P; Preti P; Mugellini A; Corradi L; Lusardi P
    J Cardiovasc Pharmacol; 1998 Oct; 32(4):616-20. PubMed ID: 9781930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.